BONK, INC. Form 8-K Summary
Business Context and Reporting Period
BONK, INC. (Nasdaq: BNKK), an emerging growth company incorporated in Delaware, filed this Current Report on November 4, 2025, regarding events occurring on October 31, 2025. The filing details the results of a Special Meeting of Stockholders held to approve corporate governance changes and significant capital transactions.
Key Financial Metrics
This filing is a corporate governance report and does not contain financial performance data. The text does not provide values for revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes and Voting Results
On October 31, 2025, stockholders voted on four proposals. A quorum was established with 82,170,394 shares voted, representing approximately 48% of the 171,441,724 shares outstanding as of the September 25, 2025 record date.
- Proposal 1 (Authorized Share Increase): Approved. Stockholders voted to increase authorized common stock from 250,000,000 to 1,000,000,000 shares.
- Votes For: 69,432,977
- Votes Against: 11,974,308
- Abstain: 763,109
- Proposal 2 (Series C Conversion & Nasdaq Rule 5635): Approved. Stockholders approved the potential issuance of 20% or more of outstanding shares upon conversion of Series C Preferred Stock below the Minimum Price, and potential issuance exceeding 19.99% which may constitute a change of control.
- Votes For: 41,603,505
- Votes Against: 3,662,518
- Abstain: 399,145
- Broker Non-Votes: 36,505,226
- Proposal 3 (Transaction Approval): Approved. Stockholders approved the Transactions defined in the Securities Purchase Agreement (SPA).
- Votes For: 40,805,866
- Votes Against: 3,493,078
- Abstain: 1,366,224
- Broker Non-Votes: 36,505,226
- Proposal 5 (Additional Issuance & Asset Issuance): Approved. Stockholders approved potential issuance of 20% or more of shares below Minimum Price and issuance of stock or assets of another company pursuant to the SPA.
- Votes For: 41,563,335
- Votes Against: 3,720,098
- Abstain: 381,735
- Broker Non-Votes: 36,505,226
Guidance, Outlook, and Risks
The filing does not contain management guidance, financial outlook, or specific risk factors beyond the implications of the approved transactions. The approval of Proposals 2, 3, and 5 indicates the Company is proceeding with a Securities Purchase Agreement that involves significant equity issuance, potentially below the Nasdaq Minimum Price, and may involve a change of control or asset acquisition.
Investor Verification Checklist
- Definitive Proxy Statement: Review the Proxy Statement filed on October 6, 2025 (amended October 15, 2025) for full details on the Securities Purchase Agreement and Revenue Sharing Agreement.
- Dilution Impact: Assess the potential dilution from the issuance of Series C Preferred Stock conversion and the new transactions approved under Proposals 2, 3, and 5.
- Nasdaq Compliance: Verify how the Company intends to maintain Nasdaq listing standards given the approval of issuances below the Minimum Price and potential change of control.
- Transaction Terms: Examine the specific terms of the "Transactions" and the identity of the purchaser signatory to the SPA.